Skip to main content
. 2015 Jun 22;33(24):2600–2608. doi: 10.1200/JCO.2015.60.8620

Fig 3.

Fig 3.

Cumulative incidence of a disease-free survival (DFS) event and death for patients with hormone receptor–positive disease and tumors ≤ 2 cm. (A) DFS event among all 2,263 patients; (B) overall survival (OS) event among all 2,263 patients; (C) DFS event among 1,092 patients with ≤ one positive lymph node; (D) OS event among 1,092 patients with ≤ one positive lymph node. Hazard ratios come from fixed effects model stratified by study.